Weimai
PrivateLast Round
Series E
Sep 1, 2025
Est. Valuation
$708M
Total Funding Raised
$278.33M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Weimai is a digital healthcare solutions provider that offers an integrated platform for full-cycle disease management, connecting patients with public healthcare institutions and doctors through AI-driven services.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Medical AI, Patient Engagement, InsurTech, NLP & Conversational AI
Business Model
B2B2C
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Weimai Comparables
Compare Weimai with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medlinker | 80% | |
| WeDoctor | 79% | |
| Beijing Yuanxin Technology Group Co., Ltd. | 73% |
Weimai Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Sep 1, 2025 | ||||
| Series D | Jan 7, 2025 | ||||
| Series C Extension | Dec 14, 2020 | ||||
| Early Funding | May 1, 2020 | ||||
| Series C | Jun 20, 2019 | ||||
Series B | Sep 13, 2018 |
Weimai Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yuanjing Capital | Series D |
| IDG Capital | Series C Extension, Series C |
| Yuanjing Capital | Series B, Angel, Series D, Series A, Series C, Series C Extension |
| Cenova Capital | Series B |
| MPC | Series B, Series C, Series A Extension, Series C Extension, Series A |
| Source Code Capital | Series B, Angel, Series D, Series A, Series C, Series C Extension |
| 千骥资本 | Series C, Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors grew 224% MoM, reaching 31.3K.
- May 1, 2025
Monthly visitors increased 181% MoM, reaching 30.1K.
Weimai Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Weimai's valuation, stock price, and market status.
Is Weimai a public or private company?
Weimai is a private company.
What is the current stock price of Weimai?
Weimai is a private company with no public stock price. No recent secondary market data is available.
How much is Weimai worth (valuation)?
Weimai's valuation is estimated at $708.0M based on funding round data.
Can I buy Weimai stock?
Weimai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Weimai's last funding round?
Weimai's most recent funding round was Series E on September 1, 2025.
Who are the main investors in Weimai?
Key investors in Weimai include IDG Capital, Cenova Capital, MPC.
Will Weimai IPO soon?
No public IPO plans have been announced for Weimai.
How can I track Weimai secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Weimai's secondary market activity and sign up for updates.